Literature DB >> 12372568

Prevalence and prognostic value of perfusion defects detected by stress technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography in asymptomatic patients with diabetes mellitus and no known coronary artery disease.

Andrea De Lorenzo1, Ronaldo S L Lima, Aristarco G Siqueira-Filho, Mauricio R Pantoja.   

Abstract

Coronary artery disease (CAD) is the leading cause of morbidity and mortality in diabetics. Early diagnosis of CAD and identification of high-risk subgroups, followed by appropriate therapy, may therefore enhance survival. This study sought to determine the value of stress myocardial perfusion single-photon emission computed tomography (SPECT) with technetium-99m sestamibi to detect perfusion defects and predict cardiac events in asymptomatic diabetics. One hundred eighty asymptomatic diabetics without known CAD who underwent 2-day stress technetium-99m sestamibi SPECT were followed up for 36 +/- 18 months. End points were defined as hard (myocardial infarction or cardiac death) or total events (myocardial infarction, cardiac death, or late revascularization). Logistic regression analysis evaluated clinical variables, type of stress, exercise treadmill test (ETT), and SPECT as predictors of end points. Perfusion defects were found in 26% of patients (15% reversible, 6% mixed, and 5% fixed). Clinical or ETT variables were not associated with perfusion defect type or with hard events. However, male gender predicted total events (chi-square 3.3; p = 0.01). An abnormal SPECT significantly increased the risk of hard events (chi-square 5.4; p = 0.001) and total events (chi-square 7.4; p = 0.0001). Extensive defects determined the highest risk of total events (chi-square 18.8; p = 0.0001). Event rates increased according to SPECT: 2% of hard events per year and 5% of total events per year in patients with normal SPECT versus 9% per year and 38% per year, respectively, in those with abnormal SPECT. Importantly, a normal SPECT identified a relatively low-risk subgroup of patients. Thus, stress technetium-99m sestamibi SPECT was useful in evaluating asymptomatic diabetics for the presence of CAD, and effectively risk-stratified this population.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12372568     DOI: 10.1016/s0002-9149(02)02702-9

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  46 in total

Review 1.  Prognostic value of gated myocardial perfusion SPECT.

Authors:  Leslee J Shaw; Ami E Iskandrian
Journal:  J Nucl Cardiol       Date:  2004 Mar-Apr       Impact factor: 5.952

2.  Asymptomatic patients with diabetes mellitus should be screened for coronary artery disease.

Authors:  Frans J Th Wackers
Journal:  J Nucl Cardiol       Date:  2006-09       Impact factor: 5.952

3.  I-123 metaiodobenzylguanidine imaging in non-insulin-dependent diabetic patients with normal myocardial perfusion scans: new insights into their increased cardiac morbidity and mortality rates.

Authors:  Nauman Mushtaq; Myron C Gerson
Journal:  J Nucl Cardiol       Date:  2006 Jan-Feb       Impact factor: 5.952

Review 4.  Single-photon emission computed tomography myocardial perfusion imaging in patients with diabetes.

Authors:  Gavin L Noble; Gary V Heller
Journal:  Curr Cardiol Rep       Date:  2005-03       Impact factor: 2.931

5.  Risk stratification in diabetic patients: a continuing challenge.

Authors:  Todd D Miller; Leslee J Shaw
Journal:  J Nucl Cardiol       Date:  2009-06-18       Impact factor: 5.952

6.  Lessons learned from the detection of ischemia in asymptomatic diabetics (DIAD) study.

Authors:  Frans J Th Wackers; Lawrence H Young
Journal:  J Nucl Cardiol       Date:  2009-08-15       Impact factor: 5.952

7.  Myocardial perfusion imaging and cardiovascular outcomes in a cancer population.

Authors:  Shalabh Chandra; Daniel J Lenihan; Wei Wei; Syed Wamique Yusuf; Ann T Tong
Journal:  Tex Heart Inst J       Date:  2009

8.  Prognostic value of myocardium perfusion imaging with a new reconstruction algorithm.

Authors:  Ronaldo Lima; Lima Ronaldo; Andrea De Lorenzo; De Lorenzo Andrea; Gabriel Camargo; Camargo Gabriel; Gabriel Oliveira; Oliveira Gabriel; Thiago Reis; Reis Thiago; Thais Peclat; Peclat Thais; Tamara Rothstein; Rothstein Tamara; Ilan Gottlieb; Gottlieb Ilan
Journal:  J Nucl Cardiol       Date:  2013-11-27       Impact factor: 5.952

9.  Prognostic predictors and outcomes in patients with abnormal myocardial perfusion imaging and angiographically insignificant coronary artery disease.

Authors:  Fadi Alqaisi; Firas Albadarin; Zehra Jaffery; Leonidas Tzogias; Muath Dawod; Gordon Jacobsen; Karthik Ananthasubramaniam
Journal:  J Nucl Cardiol       Date:  2008-07-31       Impact factor: 5.952

10.  Prevalence and predictors of an abnormal stress myocardial perfusion study in asymptomatic patients with type 2 diabetes mellitus.

Authors:  Arthur J H A Scholte; Joanne D Schuijf; Antje V Kharagjitsingh; Petra Dibbets-Schneider; Marcel P Stokkel; Ernst E van der Wall; Jeroen J Bax
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-11-05       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.